{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=quetiapine+fumarate+tablets&page=2", "query": { "intervention": "quetiapine fumarate tablets", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=quetiapine+fumarate+tablets&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=quetiapine+fumarate+tablets&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T05:55:52.607Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02901587", "title": "Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Lu AF35700 (10 mg/day)", "type": "DRUG" }, { "name": "Lu AF35700 (30 mg/day)", "type": "DRUG" }, { "name": "Quetiapine (Seroquel XR® 800 mg/day)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "21 Years to 60 Years" }, "enrollment_count": 119, "start_date": "2016-09", "completion_date": "2018-04-18", "has_results": false, "last_update_posted_date": "2019-09-12", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02901587" }, { "nct_id": "NCT01570907", "title": "Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Treatment for Bipolar I Disorder" ], "interventions": [ { "name": "Quetiapine Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 42, "start_date": "2007-06", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570907" }, { "nct_id": "NCT01570959", "title": "Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bipolar I Disorder" ], "interventions": [ { "name": "Quetiapine Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 56, "start_date": "2007-04", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 7, "location_summary": "Garden Grove, California • National City, California • North Miami, Florida + 4 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "North Miami", "state": "Florida" }, { "city": "Princeton", "state": "New Jersey" }, { "city": "Willingboro", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570959" }, { "nct_id": "NCT00090324", "title": "Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "quetiapine fumarate tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 249, "start_date": "2004-09", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2013-01-04", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 23, "location_summary": "Dothan, Alabama • Cerritos, California • Riverside, California + 20 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00090324" }, { "nct_id": "NCT01458964", "title": "Quetiapine Compared With Placebo in the Management of Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "East Tennessee State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 42, "start_date": "2008-01", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-07-09", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 1, "location_summary": "Johnson City, Tennessee", "locations": [ { "city": "Johnson City", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01458964" }, { "nct_id": "NCT01129674", "title": "A Long-Term, Open-Label, Study on Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denovo Biopharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 560, "start_date": "2010-06", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 42, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 39 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129674" }, { "nct_id": "NCT00631748", "title": "Quetiapine for the Reduction of Cocaine Use", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cocaine Dependence", "Cocaine Abuse", "Cocaine Addiction", "Drug Abuse", "Substance Abuse" ], "interventions": [ { "name": "quetiapine fumarate", "type": "DRUG" }, { "name": "Matched Placebo", "type": "DRUG" }, { "name": "Cognitive-behavioral Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Seattle Institute for Biomedical and Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2008-02", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2014-03-31", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00631748" }, { "nct_id": "NCT02431702", "title": "A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia", "Psychotic Disorders" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Oral Paliperidone ER", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Oral Risperidone", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP1M)", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP3M)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 337, "start_date": "2015-07-08", "completion_date": "2019-11-12", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Garden Grove, California • Lemon Grove, California + 31 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02431702" }, { "nct_id": "NCT00227305", "title": "Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia", "Bipolar I Disorder" ], "interventions": [ { "name": "quetiapine fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 381, "start_date": "2004-08", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2013-01-08", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 31, "location_summary": "Dothan, Alabama • Scottsdale, Arizona • Cerritos, California + 28 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00227305" }, { "nct_id": "NCT01570894", "title": "Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bipolar I Disorder" ], "interventions": [ { "name": "Quetiapine Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 42, "start_date": "2007-07", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-08T05:55:52.607Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570894" } ] }